SCHEMBL1016020

SCHEMBL1016020

C/C=C/CCCCO[CH]CC

nearest known ligand 0.35

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LPAR2 Q9HBW0 6/20 0.35
LPAR3 Q9UBY5 6/20 0.35
LPAR1 Q92633 3/20 0.35
ALDH1A1 P00352 1/20 0.30
CNR1 P21554 1/20 0.30
CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016222 0.98 LPAR2 (0.38) LPAR2LPAR3LPAR1ALDH1A1
SCHEMBL3630099 0.98 LPAR2 (0.38) LPAR2LPAR3LPAR1ALDH1A1
SCHEMBL1015433 0.93 NR1I2 (0.32) ALDH1A1
SCHEMBL3635450 0.93 NR1I2 (0.32) ALDH1A1
SCHEMBL1016618 0.84
SCHEMBL1096251 0.81 LPAR2 (0.50) LPAR2LPAR3LPAR1
SCHEMBL1015874 0.79 LPAR2 (0.31) LPAR2LPAR3LPAR1
SCHEMBL1017534 0.77 LPAR2 (0.33) LPAR2LPAR3LPAR1
SCHEMBL12354911 0.76 CDC25A (0.30)
SCHEMBL1016987 0.76 TSHR (0.46) LPAR2LPAR3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8247595-B2 Organic sulfur compound and its use for controlling harmful arthropod SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-21 US disclosed
EP-2152668-B1 ORGANIC SULFUR COMPOUND AND ITS USE FOR CONTROLLING HARMFUL ARTHROPODS SUMITOMO CHEMICAL CO (JP) 2011-01-12 EP disclosed
US-20100160434-A1 ORGANIC SULFUR COMPOUND AND ITS USE FOR CONTROLLING HARMFUL ARTHROPOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160434-A1 ORGANIC SULFUR COMPOUND AND ITS USE FOR CONTROLLING HARMFUL ARTHROPOD C5, L3MBTL3, C1S LPAR2 4014/4885LPAR3 2323/4885LPAR1 3086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.